WASHINGTON, D.C., July 14, 2026
A coalition of leading public health organizations, pediatricians, and parents has filed a federal lawsuit challenging the U.S. Food and Drug Administration’s (FDA) latest enforcement policy that allows certain unauthorized e-cigarettes and nicotine pouches to remain on the U.S. market without completing the scientific review and receiving marketing authorization required under the Family Smoking Prevention and Tobacco Control Act. The lawsuit, filed in the U.S. District Court for the District of Maryland, argues that the FDA’s May 2026 enforcement guidance unlawfully creates a pathway for thousands of unauthorized tobacco products—including flavored products that have been repeatedly identified as appealing to youth—to continue being marketed indefinitely. Plaintiffs include the Campaign for Tobacco-Free Kids, American Academy of Pediatrics, American Cancer Society Cancer Action Network, American Heart Association, American Lung Association, Truth Initiative, Parents Against Vaping, along with a pediatrician specializing in adolescent tobacco use and a parent whose children became addicted to nicotine after using flavored e-cigarettes. The legal action seeks to overturn the FDA guidance, arguing that it undermines years of progress in reducing youth nicotine use and weakens the federal regulatory framework governing tobacco products.
Coalition Challenges FDA Enforcement Guidance
According to the lawsuit, the FDA’s revised enforcement policy permits manufacturers of e-cigarettes and nicotine pouches with pending marketing applications to continue selling products without first obtaining the Marketing Granted Order (MGO) required under federal law. The plaintiffs argue that this enforcement discretion effectively creates an unauthorized “safe harbor” allowing products to remain available without demonstrating that they are appropriate for the protection of public health. The complaint further alleges that the FDA violated the Administrative Procedure Act (APA) by issuing the guidance without first conducting the required public notice-and-comment process. In addition, the lawsuit claims the agency acted in an arbitrary and capricious manner by abandoning its longstanding regulatory approach toward flavored nicotine products despite repeatedly recognizing that flavored e-cigarettes remain a primary driver of youth nicotine initiation. Plaintiffs also challenge the FDA’s proposal to publish a list of unauthorized products with pending applications, arguing that such a list could unintentionally facilitate continued commercial distribution of products that have not received regulatory approval.
Youth Nicotine Use Remains a Public Health Concern
Although recent public health initiatives have contributed to a decline in youth tobacco use across the United States, concerns remain significant. According to the 2025 National Youth Tobacco Survey, more than 2 million middle and high school students continue to use tobacco products, with e-cigarettes and nicotine pouches remaining the two most commonly used products among adolescents. Approximately 90% of youth users reported consuming flavored nicotine products, reinforcing longstanding concerns that flavored formulations increase youth appeal and nicotine addiction. The plaintiff organizations argue that allowing unauthorized flavored products to remain widely available could reverse years of public health progress while exposing another generation of young people to nicotine dependence. Medical organizations participating in the lawsuit emphasize that strong regulatory oversight remains essential for protecting children and adolescents from products specifically associated with early nicotine initiation and long-term health risks.
Advertisement
Legal Challenge May Shape Future U.S. Tobacco Regulation
The case carries broad implications for the future of U.S. tobacco regulation, particularly regarding FDA enforcement authority and oversight of emerging nicotine products. The lawsuit has been filed in the same federal court that previously ruled against a similar FDA guidance issued in 2017, determining that the agency exceeded its statutory authority by allowing unauthorized e-cigarettes to remain on the market indefinitely. Plaintiffs argue that the FDA’s latest policy repeats many of the same legal deficiencies while potentially weakening public confidence in the agency’s regulatory responsibilities. The outcome could influence future enforcement policies governing electronic nicotine delivery systems (ENDS), nicotine pouches, and other novel tobacco products while reinforcing the importance of rigorous scientific review before products reach consumers. As legal proceedings move forward, the case is expected to become a closely watched development for regulators, healthcare professionals, public health advocates, and the broader tobacco industry.
Source: Campaign for Tobacco-Free Kids press release
